STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer
Authors
Keywords
-
Journal
CLINICAL SCIENCE
Volume 133, Issue 5, Pages 645-663
Publisher
Portland Press Ltd.
Online
2019-02-20
DOI
10.1042/cs20180816
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stromal Lkb1 deficiency leads to gastrointestinal tumorigenesis involving the IL-11–JAK/STAT3 pathway
- (2017) Saara Ollila et al. JOURNAL OF CLINICAL INVESTIGATION
- STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4
- (2017) Hui Wang et al. Molecular Cancer
- Steering of carcinoma progression by the YIN/YANG interaction of STAT1/STAT3
- (2017) Karlheinz Friedrich et al. BioScience Trends
- Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia
- (2016) Bei Jin et al. CLINICAL CANCER RESEARCH
- Wnt‐induced deubiquitination FoxM1 ensures nucleus β‐catenin transactivation
- (2016) Yaohui Chen et al. EMBO JOURNAL
- NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
- (2016) Caterina Lapenta et al. JOURNAL OF IMMUNOLOGY
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes
- (2016) J Cui et al. ONCOGENE
- Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
- (2016) Chengguang Zhao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1
- (2015) Lu-Ying Wan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
- (2015) P Khongkow et al. ONCOGENE
- Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α
- (2015) Eyad Elkord et al. Oncotarget
- Activation of Vitamin D Receptor Signaling Downregulates the Expression of Nuclear FOXM1 Protein and Suppresses Pancreatic Cancer Cell Stemness
- (2014) Z. Li et al. CLINICAL CANCER RESEARCH
- Down-regulation of MicroRNA-494 via Loss of SMAD4 Increases FOXM1 and β-Catenin Signaling in Pancreatic Ductal Adenocarcinoma Cells
- (2014) Lei Li et al. GASTROENTEROLOGY
- Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma
- (2013) Tongsen Zheng et al. HEPATOLOGY
- FoxM1 mediated resistance to gefitinib in non-smallcell lung cancer cells
- (2012) Nuo Xu et al. ACTA PHARMACOLOGICA SINICA
- FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
- (2012) Yun-Yong Park et al. CARCINOGENESIS
- FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51
- (2012) N. Zhang et al. CLINICAL CANCER RESEARCH
- Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma
- (2012) Limin Xia et al. JOURNAL OF HEPATOLOGY
- FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
- (2012) Yu Wang et al. LUNG CANCER
- Overexpression of FOXM1 Is Associated With Poor Prognosis and Clinicopathologic Stage of Pancreatic Ductal Adenocarcinoma
- (2012) Jin-Tang Xia et al. PANCREAS
- Forkhead Box M1 (FoxM1) Gene Is a New STAT3 Transcriptional Factor Target and Is Essential for Proliferation, Survival and DNA Repair of K562 Cell Line
- (2012) André L. Mencalha et al. PLoS One
- Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance
- (2012) Fung Zhao et al. Frontiers of Medicine
- FOXM1: From cancer initiation to progression and treatment
- (2011) Chuay-Yeng Koo et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria
- (2011) Hongcheng Sun et al. CANCER LETTERS
- A Novel FoxM1-Caveolin Signaling Pathway Promotes Pancreatic Cancer Invasion and Metastasis
- (2011) C. Huang et al. CANCER RESEARCH
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- Multiple faces of FoxM1 transcription factor
- (2011) Tanya V. Kalin et al. CELL CYCLE
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- FoxM1 Mediates Resistance to Herceptin and Paclitaxel
- (2010) Janai R. Carr et al. CANCER RESEARCH
- Stat3 Orchestrates Tumor Development and Progression: The Achilles Heel of Head and Neck Cancers?
- (2010) M. Masuda et al. CURRENT CANCER DRUG TARGETS
- Advanced pancreatic carcinoma: current treatment and future challenges
- (2010) Anastasios Stathis et al. Nature Reviews Clinical Oncology
- FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance
- (2010) J Millour et al. ONCOGENE
- The Fox Genes in the Liver: From Organogenesis to Functional Integration
- (2010) John Le lay et al. PHYSIOLOGICAL REVIEWS
- Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
- (2008) Nuran Bektas et al. BMC CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search